c-abl has a sequence-specific enhancer binding activity

[1]  A. Levitzki,et al.  Selective interactions of transforming and normal abl proteins with ATP, tyrosine-copolymer substrates, and tyrphostins. , 1992, The Journal of biological chemistry.

[2]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[3]  S. Goff,et al.  Mice homozygous for the abl m1 mutation show poor viability and depletion of selected B and T cell populations , 1991, Cell.

[4]  J. Wang,et al.  Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins , 1991, Molecular and cellular biology.

[5]  G. Daley,et al.  Implicating the bcr/abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia. , 1991, Advances in cancer research.

[6]  F. Hoffmann,et al.  A novel tyrosine kinase-independent function of Drosophila abl correlates with proper subcellular localization , 1990, Cell.

[7]  Y. Shaul,et al.  Functional organization of the hepatitis B virus enhancer , 1990, Molecular and cellular biology.

[8]  J. Wang,et al.  Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity. , 1990, Science.

[9]  D. Baltimore,et al.  The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization , 1989, Cell.

[10]  P. Hearing,et al.  Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region , 1989, Molecular and cellular biology.

[11]  Y. Shaul,et al.  Cellular factors that interact with the hepatitis B virus enhancer , 1989, Molecular and cellular biology.

[12]  D. Baltimore,et al.  N‐terminal mutations activate the leukemogenic potential of the myristoylated form of c‐abl. , 1989, The EMBO journal.

[13]  T. Pawson,et al.  Non-catalytic domains of cytoplasmic protein-tyrosine kinases: regulatory elements in signal transduction. , 1988, Oncogene.

[14]  M. L. Le Beau,et al.  Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis. , 1988, Blood.

[15]  P. Sharp,et al.  Molecular cloning of an enhancer binding protein:Isolation by screening of an expression library with a recognition site DNA , 1988, Cell.

[16]  O. Witte,et al.  Normal cellular and transformation-associated abl proteins share common sites for protein kinase C phosphorylation. , 1987, Molecular and cellular biology.

[17]  M. Greaves,et al.  A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia positive acute lymphoblastic leukaemia , 1987, Nature.

[18]  R. Kurzrock,et al.  A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia , 1987, Nature.

[19]  O. Witte,et al.  Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. , 1987, Science.

[20]  G. Daley,et al.  Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Bruce A. Roe,et al.  Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene , 1986, Cell.

[22]  G. Daley,et al.  The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. , 1986, Science.

[23]  G. Daley,et al.  Alternative 5′ exons in c-abl mRNA , 1986, Cell.

[24]  D. Baltimore,et al.  Structural modification of c-abl in lymphoma and leukemia. , 1986, Current topics in microbiology and immunology.

[25]  E. Canaani,et al.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.

[26]  Susan M. Watanabe,et al.  An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.

[27]  Rosalind C. Lee,et al.  The mouse c-abl locus: Molecular cloning and characterization , 1984, Cell.

[28]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.

[29]  D. Cleveland.  Peptide mapping in one dimension by limited proteolysis of sodium dodecyl sulfate-solubilized proteins. , 1983, Methods in enzymology.